Tags

Type your tag names separated by a space and hit enter

SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity.
Pan Afr Med J. 2021; 39:255.PA

Abstract

In response to COVID-19 pandemic, the Zimbabwe government put in place various rigorous measures to curb the spread of the virus. Although roll-out and access to COVID-19 vaccines in Africa have been slow, the World Health Organization (WHO)-led COVID-19 Vaccines Global Access (COVAX) consortium and the African vaccine acquisition task team are striving to provide 720 million doses of COVID-19 vaccines to achieve 60% coverage in Africa by June, 2022. In line with this, the Zimbabwe vaccination programme commenced on the 26th February 2021 and as of 9th June 2021, approximately, 2.6% of the population have been fully vaccinated in the country. Although the COVID-19 pandemic has crippled the economy and caused significant strain on the public health system, much has been done in the country since the first case was recorded (20th March 2020). However, much more needs to be done to finally reach the expected 60% herd immunity by June 2022.

Authors+Show Affiliations

Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

34707756

Citation

Kouamou, Vinie, et al. "SARS-CoV-2 in Zimbabwe: Milestones and Challenges Faced Towards Achieving the Expected 60% Herd Immunity." The Pan African Medical Journal, vol. 39, 2021, p. 255.
Kouamou V, Matarise R, Santos ED, et al. SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity. Pan Afr Med J. 2021;39:255.
Kouamou, V., Matarise, R., Santos, E. D., Elose, N., & Manasa, J. (2021). SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity. The Pan African Medical Journal, 39, 255. https://doi.org/10.11604/pamj.2021.39.255.30331
Kouamou V, et al. SARS-CoV-2 in Zimbabwe: Milestones and Challenges Faced Towards Achieving the Expected 60% Herd Immunity. Pan Afr Med J. 2021;39:255. PubMed PMID: 34707756.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity. AU - Kouamou,Vinie, AU - Matarise,Richard, AU - Santos,Elizabeth Dos, AU - Elose,Nyasha, AU - Manasa,Justen, Y1 - 2021/08/20/ PY - 2021/06/13/received PY - 2021/08/18/accepted PY - 2021/10/28/entrez PY - 2021/10/29/pubmed PY - 2021/11/3/medline KW - COVID-19 KW - Vaccine KW - Zimbabwe SP - 255 EP - 255 JF - The Pan African medical journal JO - Pan Afr Med J VL - 39 N2 - In response to COVID-19 pandemic, the Zimbabwe government put in place various rigorous measures to curb the spread of the virus. Although roll-out and access to COVID-19 vaccines in Africa have been slow, the World Health Organization (WHO)-led COVID-19 Vaccines Global Access (COVAX) consortium and the African vaccine acquisition task team are striving to provide 720 million doses of COVID-19 vaccines to achieve 60% coverage in Africa by June, 2022. In line with this, the Zimbabwe vaccination programme commenced on the 26th February 2021 and as of 9th June 2021, approximately, 2.6% of the population have been fully vaccinated in the country. Although the COVID-19 pandemic has crippled the economy and caused significant strain on the public health system, much has been done in the country since the first case was recorded (20th March 2020). However, much more needs to be done to finally reach the expected 60% herd immunity by June 2022. SN - 1937-8688 UR - https://www.unboundmedicine.com/medline/citation/34707756/SARS_CoV_2_in_Zimbabwe:_milestones_and_challenges_faced_towards_achieving_the_expected_60_herd_immunity_ L2 - https://www.panafrican-med-journal.com/content/article/39/255/full/ DB - PRIME DP - Unbound Medicine ER -